Influence of local skin temperature and choice of insulin analog on catheter occlusion rates during continuous insulin infusion: An exploratory study

Diabetes Technology and Therapeutics

Volumn 14, Issue 11, 2012, Pages 1018-1022

  Naik, Sarita ^a   Kerr, David ^a   Begley, Joseph ^b   Morton, John ^a  

^a ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

^b POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN ASPART; INSULIN GLULISINE;

ADULT; ARTICLE; CATHETER OCCLUSION; COMPARATIVE STUDY; CONTINUOUS INFUSION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG CHOICE; FEMALE; HUMAN; HUMAN EXPERIMENT; INSULIN INFUSION; INSULIN PUMP; MALE; MEAL; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SKIN TEMPERATURE;

ADULT; CATHETERS, INDWELLING; CROSS-OVER STUDIES; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; REGIONAL BLOOD FLOW; REPRODUCIBILITY OF RESULTS; SKIN TEMPERATURE; SKINFOLD THICKNESS; YOUNG ADULT;

EID: 84868026810     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2012.0080     Document Type: Article

References (15)

1. Renard E: Insulin pump use in Europe. Diabetes Technol Ther 2010;12(Suppl 1):S-29-S-32.
2. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-986.
3. Guerci B, Meyer L, Sallé A, Charrié A, Dousset B, Ziegler O, Drouin P: Comparison of metabolic deterioration between insulin analog and regular insulin after a 5-hour interruption of a continuous subcutaneous insulin infusion in type 1 diabetic patients. J Clin Endocrinol Metab 1999;84:2673-2678. (Pubitemid 30641991)
4. Raz I, Weiss R, Yegorchikov Y, Bitton G, Nagar R, Pesach B: Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion. Clin Ther 2009;31:980-987.
5. Hirsch IB, Farkas-Hirsch R, McGill JB: Catheter obstruction with continuous subcutaneous insulin infusion. Effect of insulin concentration. Diabetes Care 1992;15:593-594.
6. Wolpert HA, Faradji RN, Bonner-Weir S, Lipes MA: Metabolic decompensation in pump users due to lispro insulin precipitation. BMJ 2002;324:1253. (Pubitemid 34553564)
7. Bode BW: Comparison of pharmacokinetic properties, physicochemical stability, and pump compatibility of 3 rapid-acting insulin analogues-aspart, lispro, and glulisine. Endocr Pract 2011;17:271-280.
8. Kerr D, Morton J, Whately-Smith C, Everett J, Begley JP:Laboratory-based non-clinical comparison of occlusion rates using three rapid-acting insulin analogs in continuous subcutaneous insulin infusion catheters using low flow rates. J Diabetes Sci Technol 2008;2:450-455.
9. Sindelka G, Heinemann L, Berger M, Frenck W, Chantelau E: Effect of insulin concentration, subcutaneous fat thickness and skin temperature on subcutaneous insulin absorption in healthy subjects. Diabetologia 1994;37:377-380. (Pubitemid 24113569)
10. DeFelippis MR, Bell MA, Heyob JA, Storms SM: In vitro stability of insulin lispro in continuous subcutaneous insulin infusion. Diabetes Technol Ther 2006;8:358-368. (Pubitemid 46100529)
11. Senstius J, Harboe E, Westermann H: In vitro stability of insulin aspart in simulated continuous subcutaneous insulin infusion using a MiniMed 508 insulin pump. Diabetes Technol Ther 2007;9:75-79.
12. van Bon AC, Bode BW, Sert-Langeron C, Devries JH, Charpentier G: Insulin glulisine compared to insulin aspart and to insulin lispro administered by continuous subcutaneous insulin infusion in patients with type 1 diabetes: a randomized controlled trial. Diabetes Technol Ther 2011;13: 607-614.
13. Fuld K, Conrad B, Buckingham B, Wilson DM: Insulin pumps in young children. Diabetes Technol Ther 2010; 12(Suppl 1):S-67-S-71.
14. Johansson UB, Adamson U, Lins PE, Wredling R: Patient management of long-term continuous subcutaneous insulin infusion. J Adv Nurs 2005;51:112-118. (Pubitemid 40977312)
15. Nassar AA, Childs RD, Boyle ME, Jameson KA, Fowke M, Waters KR, Hovan MJ, Cook CB: Diabetes in the desert: what do patients know about the heat? J Diabetes Sci Technol 2010;4:1156-1163.